middle.news
Elixinol’s Q4 Surge: Revenue Up, Costs Down, Cash Flow Turns Positive
10:34am on Thursday 29th of January, 2026 AEDT
•
Consumer Staples
Read Story
Elixinol’s Q4 Surge: Revenue Up, Costs Down, Cash Flow Turns Positive
10:34am on Thursday 29th of January, 2026 AEDT
Key Points
Q4 FY25 revenue rose 9.5% quarter-on-quarter to $4.1 million
FY25 revenue increased 3.6% year-on-year to $15.5 million, boosted by Healthy Chef acquisition
Operating costs reduced by approximately 30% compared to prior year quarter
First underlying operating cash flow positive quarter achieved
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ELIXINOL WELLNESS (ASX:EXL)
OPEN ARTICLE